Immune checkpoint targeting as anti-cancer immunotherapy: promises, questions, challenges and the need for predictive biomarkers at ASCO 2015

H Pandha; G Pawelec

doi:10.1007/s00262-015-1748-7

Back

Journal article

Immune checkpoint targeting as anti-cancer immunotherapy: promises, questions, challenges and the need for predictive biomarkers at ASCO 2015

H Pandha and G Pawelec

CANCER IMMUNOLOGY IMMUNOTHERAPY, Vol.64(9), pp.1071-1074

01/09/2015

DOI: https://doi.org/10.1007/s00262-015-1748-7

Abstract

Science & Technology

Life Sciences & Biomedicine

Oncology

Immunology

Immune checkpoint

Anti-CTLA-4

PD-1

PD-L1

Biomarkers

ASCO 2015

PD-1 BLOCKADE

CANCER

CELLS

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000359819400001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

37 Record Views

5 Times Cited - Web of Science

Details

Title: Immune checkpoint targeting as anti-cancer immunotherapy: promises, questions, challenges and the need for predictive biomarkers at ASCO 2015
Creators: H Pandha
G Pawelec
Publication Details: CANCER IMMUNOLOGY IMMUNOTHERAPY, Vol.64(9), pp.1071-1074
Publisher: SPRINGER
Date published: 01/09/2015
Date submitted: 17/05/2017
Identifiers: 99511034602346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

Immune checkpoint targeting as anti-cancer immunotherapy: promises, questions, challenges and the need for predictive biomarkers at ASCO 2015

Abstract

Files and links (1)

Metrics

Details

Usage Policy